{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T22:30:39Z","timestamp":1771021839133,"version":"3.50.1"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,4,15]]},"DOI":"10.2169\/internalmedicine.6094-20","type":"journal-article","created":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T22:09:21Z","timestamp":1605478161000},"page":"1283-1286","source":"Crossref","is-referenced-by-count":4,"title":["Adult Krabbe Disease That Was Successfully Treated with Intravenous Immunoglobulin"],"prefix":"10.2169","volume":"60","author":[{"given":"Ryosuke","family":"Fukazawa","sequence":"first","affiliation":[{"name":"Department of Neurology, Saiseikai Shiga Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Minami Kyoto Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Minami Kyoto Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toko","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Sakai","sequence":"additional","affiliation":[{"name":"Child Healthcare and Genetic Science Laboratory, Division of Health Sciences, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saiseikai Shiga Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Van Der Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 17: 356-363, 2010."},{"key":"2","unstructured":"2. Suzuki Y. Globoid cell leucodystrophy (Krabbe&apos;s disease): deficiency of galactocerebroside beta-galactosidase. Proc Natl Acad Sci 66: 302-309, 1970."},{"key":"3","unstructured":"3. Wegener DA, Suzuki K, Suzuki Y, et al. Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease). In: The Metabolic &amp; Molecular Basis of Inherited Disease. 8th ed. Scriver R, Beaudet AL, Sly WS, et al., Eds. McGraw-Hill, New York, 2001: 3669-3694."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hossain MA, Otomo T, Saito S, et al. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form. Gene 534: 144-154, 2013.","DOI":"10.1016\/j.gene.2013.11.003"},{"key":"5","unstructured":"5. Rita DG, Miguel AGS, Edi LS, et al. Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy. Am J Hum Genet 59: 1233-1242, 1996."},{"key":"6","unstructured":"6. Edwin HK, Srinivasa R, William K. Late-onset Krabbe disease (Globoid Cell Leukodystrophy): clinical and biochemical features of 15 cases. Dev Neurosci 13: 232-239, 1991."},{"key":"7","unstructured":"7. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17: 405-424, 2015."},{"key":"8","unstructured":"8. Debs R, Froissart R, Aubourg P, Papeix C, Douillard C, Degos B. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherit Metab Dis 36: 859-868, 2013."},{"key":"9","unstructured":"9. Sakai N. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment. Brain Dev 31: 485-487, 2009."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kondo Y, Wenger AD, Gallo V, Duncan ID. Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme mice. Proc Natl Acad Sci 102: 18670-18675, 2005.","DOI":"10.1073\/pnas.0506473102"},{"key":"11","unstructured":"11. Goebel HH, Harzer K, Emst JP, Bohl J, Klein H. Late-onset globoid cell leukodystrophy: unusual ultrastructual pathology and subtotal \u03b2-galactocerebrosidase deficiency. J Child Neurol 5: 299-307, 1990."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mamada N, Nakamagoe K, Shioya A, et al. Adult-onset Krabbe disease presenting as acute hemiparesis and progressive demyelination detected by diffusion-weighted imaging. J Neurol Sci 367: 326-328, 2016.","DOI":"10.1016\/j.jns.2016.06.026"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rachana D, Biswaroop C, Sheffali G, et al. Leukodystrophy presenting as acute-onset polyradiculoneuropathy. Pediatr Neurol 50: 616-618, 2014.","DOI":"10.1016\/j.pediatrneurol.2014.01.028"},{"key":"14","unstructured":"14. Iannaccone S, Nemni R, Fazio R, Quattrini A, Lacerenza M, Smirne S. Polyneuropathy with antibodies to sulphatide and decreased level of arylsulphatase A. J Neurol 240: 260-261, 1993."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Eric RS, Jeanne MFP, Hope AS, et al. Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy. Am J Pathol 184: 382-396, 2014.","DOI":"10.1016\/j.ajpath.2013.10.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Santambrogio S, Ricca A, Maderna C, et al. The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development. Hum Mol Genet 21: 4732-4750, 2012.","DOI":"10.1093\/hmg\/dds313"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gregory BP, Magdalena AP. Neuroimmune mechanisms in Krabbe&apos;s disease. J Neurosci Res 94: 1341-1348, 2016.","DOI":"10.1002\/jnr.23804"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/8\/60_6094-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T04:04:49Z","timestamp":1618632289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/8\/60_6094-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6094-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}